Procaps Group Sa Stock Cash And Equivalents
| PROC Stock | USD 1.11 0.54 94.74% |
Procaps Group SA fundamentals help investors to digest information that contributes to Procaps Group's financial success or failures. It also enables traders to predict the movement of Procaps Stock. The fundamental analysis module provides a way to measure Procaps Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procaps Group stock.
Procaps | Cash And Equivalents |
Procaps Group SA Company Cash And Equivalents Analysis
Procaps Group's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Procaps Group Cash And Equivalents | 37.55 M |
Most of Procaps Group's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procaps Group SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Procaps Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Procaps Group is extremely important. It helps to project a fair market value of Procaps Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Procaps Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Procaps Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Procaps Group's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Procaps Group SA has 37.55 M in Cash And Equivalents. This is 95.43% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.61% higher than that of the company.
Procaps Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procaps Group's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procaps Group could also be used in its relative valuation, which is a method of valuing Procaps Group by comparing valuation metrics of similar companies.Procaps Group is currently under evaluation in cash and equivalents category among its peers.
Procaps Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.0628 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 389.32 M | ||||
| Shares Outstanding | 112.82 M | ||||
| Shares Owned By Insiders | 83.02 % | ||||
| Shares Owned By Institutions | 2.81 % | ||||
| Number Of Shares Shorted | 20.49 K | ||||
| Price To Book | 3.18 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 414.1 M | ||||
| Gross Profit | 191.31 M | ||||
| EBITDA | 57.06 M | ||||
| Net Income | 52.2 M | ||||
| Cash And Equivalents | 37.55 M | ||||
| Cash Per Share | 0.37 X | ||||
| Total Debt | 285.94 M | ||||
| Debt To Equity | 6.02 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | 62.99 M | ||||
| Short Ratio | 1.65 X | ||||
| Earnings Per Share | 0.51 X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 5.5 K | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 125.23 M | ||||
| Total Asset | 460.19 M | ||||
| Retained Earnings | (391.51 M) | ||||
| Working Capital | (70.93 M) | ||||
| Net Asset | 460.19 M |
About Procaps Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procaps Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procaps Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procaps Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Procaps Group SA is a strong investment it is important to analyze Procaps Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Procaps Group's future performance. For an informed investment choice regarding Procaps Stock, refer to the following important reports:Check out Procaps Group Piotroski F Score and Procaps Group Altman Z Score analysis. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procaps Group. If investors know Procaps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procaps Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share 0.51 | Revenue Per Share 4.097 | Quarterly Revenue Growth 0.073 | Return On Assets 0.0628 |
The market value of Procaps Group SA is measured differently than its book value, which is the value of Procaps that is recorded on the company's balance sheet. Investors also form their own opinion of Procaps Group's value that differs from its market value or its book value, called intrinsic value, which is Procaps Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procaps Group's market value can be influenced by many factors that don't directly affect Procaps Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procaps Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procaps Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procaps Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.